<DOC>
	<DOCNO>NCT00082589</DOCNO>
	<brief_summary>The purpose study determine eplerenone effective treatment mild moderate heart failure</brief_summary>
	<brief_title>The Purpose This Study Determine Eplerenone Effective Treatment Mild Moderate Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Current symptom consistent mild moderate heart failure ( NYHA functional class II III ) LVEF ( leave ventricular ejection fraction ) &lt; 35 % equilibriumgated RVG screen Therapy angiotensin convert enzyme inhibitor ( ACEI ) angiotensin receptor blocker ( ARB ) betablocker ( BB ) ( unless document intolerance ) least 3 month duration dose adjust within previous 4 week Current decompensated heart failure heart failure hospitalization severe heart failure ( NYHA functional class IV ) within 6 month screen Use eplerenone spironolactone within 30 day randomization 7 day within previous 6 month</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>